- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Number of clinical trials for rare diseases in Italy 2018, by type of drug
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Number of clinical trials for rare diseases in Italy 2018, by type of drug
Number of clinical trials* to treat rare diseases in Italy in 2018, by type of drug
by Statista Research Department,
last edited
Nov 28, 2019
This statistic depicts the number of clinical trials for rare diseases in Italy in 2018, broken down by type of drug. According to the data, 123 trials were based on chemical active ingredients, whereas only 3 of them contained biological or biotechnological active ingredients.
Number of clinical trials* to treat rare diseases in Italy in 2018, by type of drug
| Number of clinical trials | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| Number of clinical trials | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Register now
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Statista Research Department,
last edited
Nov 28, 2019
This statistic depicts the number of clinical trials for rare diseases in Italy in 2018, broken down by type of drug. According to the data, 123 trials were based on chemical active ingredients, whereas only 3 of them contained biological or biotechnological active ingredients.
- Show sources information
- Show publisher information
- Release date
- October 2019
- Region
- Italy
- Survey time period
- 2018
- Supplementary notes
- *Figures refer to the number of clinical trials authorized by the Italian Medicines Agency.
Source
- Show sources information
- Show publisher information
- Release date
- October 2019
More information
- Region
- Italy
- Survey time period
- 2018
- Supplementary notes
- *Figures refer to the number of clinical trials authorized by the Italian Medicines Agency.
Other statistics on the topic
+Pharmaceutical Products & Market
Total global pharmaceutical R&D spending 2010-2024
Pharmaceutical Products & Market
Research and development expenditure: U.S. pharmaceutical industry 1995-2018
+Pharmaceutical Products & Market
Leading global contract research organizations based on revenue 2017
+Pharmaceutical Products & Market
Total number of registered clinical studies worldwide since 2000
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Clinical trials"
- R&D overview
The most important statistics
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)Total global pharmaceutical R&D spending 2010-2024
- Percentage of spending on research and development of total revenue from 2013 to 2017, by industrial sector*Industry sectors - expenditure on research and development 2013-2017
- Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2019 (in million U.S. dollars)Top pharmaceutical R&D projects based on net present value May 2019
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2018 (in billion U.S. dollars)*Research and development expenditure: U.S. pharmaceutical industry 1995-2018
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)Research and development in European pharmaceutical industry by country 2017
- Total clinical research funding by the National Institutes for Health (NIH) from FY 2013 to FY 2020 (in million U.S. dollars)Total clinical research funding by National Institutes for Health 2013-2020
- Top R&D companies
The most important statistics
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
- World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*Top 50 global pharmaceutical and biotech companies by R&D intensity in 2017/2018
- World's top 50 pharmaceutical and biotechnology companies based on R&D spending growth in 2017/2018Top pharmaceutical companies in R&D spending growth 2017-2018
- Number of patients who took part in clinical trials for pharmaceutical company Roche from 2009 to 2017*Roche: participation of patients in clinical trials 2009-2017
- Top global contract research organizations (CROs) based on 2017 revenue (in million U.S. dollars)Leading global contract research organizations based on revenue 2017
- Clinical studies
The most important statistics
- Complexity of clinical trials compared in 2001-2005 and 2011-2015Comparison between the complexity of clinical trials 2001-2015
- Increase in clinical trials' complexity between 2001-2005 and 2011-2015Increase in clinical trials' complexity 2001-2015
- Number of registered clinical studies worldwide by location as of October 2019Number of registered clinical studies by location worldwide 2019
- Percentage of registered clinical studies worldwide by location as of October 2019Percent of registered clinical studies worldwide by location 2019
- Percentage of registered recruiting clinical studies worldwide by location as of October 2019Share of recruiting clinical studies worldwide by location 2019
- Total number of registered clinical studies worldwide since 2000 (as of October 2019)*Total number of registered clinical studies worldwide since 2000
- Total number of registered clinical studies with posted results worldwide since 2009 (as of October 2019)*Total number of registered clinical studies with posted results worldwide 2009-2019
- Participation
The most important statistics
- Percentage of population enrolled in clinical trials in selected countries worldwide as of 2016Clinical trial enrollment by select country and region 2016
- Top 20 countries by number of clinical trial participants in 2015-2016Top clinical trial participant countries 2015-2016, by number
- Top 20 clinical trial participant countries worldwide in 2015-2016, by share of participants (in percentage)Top clinical trial participant countries worldwide 2015-16, by share
- Number of clinical trial participants in the U.S. and rest of the world in 2016, by therapeutic areaClinical trial participants U.S. vs. rest of world by therapy area 2016
- Gender share of clinical trial participants worldwide in 2015-2016, by geographic locationClinical trial participants gender share worldwide 2015-16, by geographic location
- Ethnicity share of clinical trial participants worldwide in 2015-2016, by geographic location (in percentage)Clinical trial participants ethnicity share worldwide 2015-16, by geographic location
- Costs and market
The most important statistics
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*Pharmaceuticals: cost of drug development in the U.S. since 1975
- Total R&D costs for selected cancer drugs on the market as of 2017 (in million U.S. dollars)Total R&D costs of select cancer drugs 2017
- Market share of clinical trials worldwide by segment as of 2016Market share of clinical trials worldwide by segment
- Clinical contract research organization (CRO) market worldwide from 2011 to 2020 (in billion U.S. dollars)Clinical CRO market size worldwide 2011-2020
- Size of the U.S. market for healthcare contract research outsourcing (CRO) from 2016 to 2022, by type (in million U.S. dollars)Size of U.S. healthcare CRO market 2016-2022 by type
- Size of the total U.S. clinical trial supplies market from 2016 to 2025 (in million U.S. dollars)Size of total U.S. clinical trial supplies market 2016-2025
- Success rates
The most important statistics
- Probability of success for drugs in the U.S. in different development phases between 2006 and 2015U.S. drug development phase success rates 2006-2015
- Probability of Phase II success for new drugs in select disease areas in the U.S. between 2006 and 2015U.S. drug development Phase II success rates 2006-2015, by disease area
- The probability of Phase III success for new drugs in select disease areas in the U.S. between 2006 and 2015U.S. drug development Phase III success rates from 2006 to 2015, by disease area
- Probability of success for oncology vs non-oncology drugs in the U.S. in the different development phases from 2006 to 2015U.S. development Phase success rates for oncology and non oncology drugs 2006-2015
- Probability of success for new drugs in the U.S. by development phase between 2006 and 2015, by drug classification U.S. drug development Phase success rates, by drug classification 2006-2015
- Probability of success for new drugs in the U.S. with and without selection biomarkers by development phase between 2006 and 2015U.S. development phase success rates for drugs with and without biomarkers 2006-2015
- Approvals, launches, setbacks
The most important statistics
- Number of new chemical or biological entities developed between 1992 and 2018, by region of originPharmaceutical industry - number of new substances 1992-2018
- Total number of novel drugs approved by CDER from 2008 to 2018Number of novel drugs approved annually by CDER 2008-2018
- Percentage of drugs approved by the U.S. Center for Drug Evaluation and Research (CDER) in 2018 that met select key measurementsKey measurements of U.S. CDER drug approvals in 2018
- Number of first premarket approvals (PMA/HDE) granted by the FDA for medtech products from 2005 to 2018FDA first premarket approvals for medtech products granted 2005-2018
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)Projection of top 2018 pharma and biotech launches by revenue 2022
- Number of unsuccessful Alzheimer’s drugs in development in the U.S. from 1998 to 2017Number of unsuccessful Alzheimer’s drugs in development in the U.S. 1998-2017
- Unsuccessful attempts and new drugs for select cancer types between 1998 and 2014Unsuccessful attempts and new drugs for cancer types 1998-2014
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: You might find this interesting as well
Statistics
- Number of clinical trials in Italy 2018, by type of drug
- Number of clinical trials for rare diseases in Italy 2018, by funding institution
- Number of clinical trials in Italy 2018, by phase
- Share of approved clinical trials out of the total EU approvals in Italy 2013-2018
- Number of participants in drug clinical trials in Italy 2018, by age group
- Sales volume of drugs in Italy 2018, by ATC
- Obesity drugs clinical pipeline U.S. 2018, by type and phase
- Clinical trial costs by select component and phase
- Unsuccessful developing melanoma drugs in the U.S. 1998-2014
- Median length of orphan and non-orphan drugs in phase III trial 2015
- Average clinical trial site year density globally from 2006-2012, by country
- Number of new cancer pharmaceuticals approved by EMA in Sweden 2014-2017
- Clinical trial site-years by country development status from 2006 to 2012
- Average prices of Gleevec - selected countries 2013
- Clinical trial sites by country development status from 2006 to 2012
- Select supply chain technologies utilized by clinical trial organizations 2016
- Revenue as a part of R&D spending for select cancer drugs 2017
- Clinical trial starts for new obesity drugs U.S. 2008-2017
- Top therapy spending areas in pharmerging markets 2018
- Useful forecasting tools for clinical trial supplies globally 2016
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Yes, save as favorite!
...and make my research life easier.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.